Carlisle Companies Incorporated (CSL)

Current ratio

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Total current assets US$ in thousands 3,408,100 2,245,000 2,150,900 2,209,300 1,752,000
Total current liabilities US$ in thousands 1,186,300 1,078,400 1,169,500 646,200 899,000
Current ratio 2.87 2.08 1.84 3.42 1.95

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $3,408,100K ÷ $1,186,300K
= 2.87

The current ratio of Carlisle Companies Inc. has fluctuated over the past five years. In 2023, the company's current ratio stood at 2.87, indicating that it had $2.87 in current assets to cover each dollar of current liabilities. This represents a significant improvement from the previous year's ratio of 2.08.

In 2022, the current ratio had shown an increase compared to 2021 when it was 1.84. The higher current ratio in 2022 suggests that Carlisle had strengthened its ability to meet short-term obligations using its current assets.

In 2020, the company had a notably high current ratio of 3.42, indicating strong liquidity and ability to cover short-term liabilities. However, in 2019, the ratio was lower at 1.95, which might have raised concerns about the company's ability to meet its short-term obligations at that time.

Overall, the trend in Carlisle's current ratio shows fluctuations, but the recent improvement in 2023 suggests a potentially strengthened liquidity position compared to previous years.


Peer comparison

Dec 31, 2023

Company name
Symbol
Current ratio
Carlisle Companies Incorporated
CSL
2.87
West Pharmaceutical Services Inc
WST
2.88